“The PMI Cohort Program will enable scientists to detect and delineate the key genetic drivers of disease across the diverse population of patients we serve – and move us closer to fulfilling the promise of precision medicine.” David Goldstein, director of the Institute for Genomic Medicine at Columbia.
Hirst III Professor of Oncology in Pathology at Weill Cornell Medicine, and director of the precision medicine program at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, who is co-leading the grant with Dr. Mark Rubin, director of the Englander Institute for Precision Medicine and the Homer T. “As doctors and scientists, we are committed to providing our patients with the very best, most cutting-edge care to ensure that illness isn’t a barrier in their everyday lives,” said Dr. Importantly, the program will also focus on ways to increase a person’s chances of remaining healthy throughout life. volunteers in an effort to extend the success of precision medicine in some cancers to many other diseases. This landmark research program aims to engage 1 million or more diverse U.S. Columbia and Weill Cornell Medicine, along with several other medical centers and institutions across the country, will provide expertise and infrastructure to launch the PMI Cohort Program. Precision medicine, an emerging approach for disease treatment and prevention, takes into account individual variability in genes, environment and lifestyle for each person. The grant, which could total $46.5 million over five years, will enable researchers to enroll patients in the Cohort Program of President Barack Obama’s Precision Medicine Initiative (PMI) in order to better understand the genetic and other biological drivers of disease, and how they relate to overall health.
Weill Cornell Medicine and Columbia University Medical Center, in collaboration with NewYork-Presbyterian and NYC Health + Hospitals/Harlem, have been awarded a grant from the National Institutes of Health worth $4 million in the first year of funding to improve physicians’ ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics.
0 kommentar(er)
